#790 — The Industry Wire

April 3, 2026 Brian Casey 0 min read
  1. Trump to levy 100% tariffs on drugmakers that haven’t cut deals.
  2. FDA approves Eli Lilly’s Foundayo oral GLP-1 weight-loss pill. 
  3. FDA offers guidance on compounded GLP-1 drugs.
  4. Rise in payor denials cuts revenue for healthcare providers. 
  5. Insurers release denial rates for prior authorizations. 
  6. Trump’s 2027 budget request cuts HHS spending by 12%. 
  7. HHS reverses Biden-era health tech changes, restores ONC designation. 
  8. Healthcare employment jumps in March to 76k jobs. 
  9. Wearable device firm Whoop raises $575M. 
  10. Doc gets prison for giving patients CPAP machines his kids “fixed.”
Get every issue of The Imaging Wire, delivered right to your inbox.

You might also like

Radiology Education April 20, 2026

Radiologist Training Stagnates April 20, 2026

The number of new radiologists being trained in the U.S. has largely stagnated, even as concerns grow over workforce shortages. A new analysis in JACR underscores the […]

Picture of doctors and a dollar sign graphic.

Radiologists April 16, 2026

Radiologist Salaries Grow 9% April 16, 2026

It’s not quite double-digit growth, but it’s pretty close. The latest physician salary report from Medscape reveals that radiologist salaries grew 9% in 2025, with medical imaging […]

Artificial Intelligence April 13, 2026

AI’s ROI Paradox April 13, 2026

As radiology AI slowly moves from pilot projects to widespread clinical adoption, a new survey reveals a paradox: The technology is popular with radiologists, but few imaging […]